FDA’s 2014 Social Media Guidance Agenda Published: Space Limitation, Correcting Third Party Misinformation, & Use of Links Included

The FDA has just published its “Guidance Agenda: New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2014,” which includes these promised guidances under the “Advertising” category:

•  Brief Summary and Adequate Information for Use: Disclosing Risk Information in Consumer- Directed Print Advertisements and Promotional Labeling for Prescription Drugs 
• Considerations for Regulatory Submissions of Promotional Labeling and Advertising Materials including Submissions in Electronic Format 
• Direct-to-Consumer Television Advertisements – FDAAA DTC Television Pre-review Program 
• Internet/Social Media Platforms with Character Space Limitations: Presenting Risk and Benefit
  Information for Prescription Drugs and Medical Devices 
• Internet/Social Media Platforms: Correcting Independent-Third Party Misinformation About
  Prescription Drugs and Medical Devices 
• Internet/Social Media Advertising and Promotional Labeling of Prescription Drugs and Medical
  Devices – Use of Links